Skip to main content
Normal View

Health Services

Dáil Éireann Debate, Tuesday - 30 January 2024

Tuesday, 30 January 2024

Questions (523, 524, 525, 526, 527, 528)

Patrick Costello

Question:

523. Deputy Patrick Costello asked the Minister for Health if he will outline the clinical purpose of the National Gender Service having nine adults on GnRHa alone as referenced in a 2022 report (details supplied); and if he will make a statement on the matter. [3892/24]

View answer

Patrick Costello

Question:

524. Deputy Patrick Costello asked the Minister for Health if he will outline the National Gender Service's views on progesterone therapy and the medical literature which underpins this; and if he will make a statement on the matter. [3893/24]

View answer

Patrick Costello

Question:

525. Deputy Patrick Costello asked the Minister for Health if he will outline the gender services whose assessment is considered sufficient to avoid having to repeat an initial assessment by the National Gender Service; the number of referrals to the National Gender Service which did not have to repeat an initial assessment in 2023; and if he will make a statement on the matter. [3894/24]

View answer

Patrick Costello

Question:

526. Deputy Patrick Costello asked the Minister for Health if he will outline the evidence to support a claim by the National Gender Service on a recent television programme (details supplied) that prior to the use of blockers, most gender non-conforming children through puberty became comfortable with their bodies and assigned gender; and if he will make a statement on the matter. [3895/24]

View answer

Patrick Costello

Question:

527. Deputy Patrick Costello asked the Minister for Health if he will outline the National Gender Service's views on the exploratory or questioning model of care, as referenced on a recent television programme (details supplied); and if he will make a statement on the matter. [3896/24]

View answer

Patrick Costello

Question:

528. Deputy Patrick Costello asked the Minister for Health if he will outline the National Gender Service's views on the harms and benefits of monitoring the hormone concentrations of people accessing transgender services; and if he will make a statement on the matter. [3897/24]

View answer

Written answers

I propose to take Questions Nos. 523, 524, 525, 526, 527 and 528 together.

As this is a service matter I have referred the question to the HSE for direct reply to the Deputy.

Question No. 524 answered with Question No. 523.
Question No. 525 answered with Question No. 523.
Question No. 526 answered with Question No. 523.
Question No. 527 answered with Question No. 523.
Question No. 528 answered with Question No. 523.
Top
Share